The reopening of the Chinese economy after the pandemic could present investment opportunities for those interested in the Chinese market.
Tag: investment
MTQ Corporation (SGX:M05) – Promising Business Turnaround Potential with Strong Financial Performance
MTQ Corporation SGX:M05 presents an attractive investment opportunity with its strong financials and potential for business turnaround.
Wabash National Corporation (WNC:NYSE) – Driving Growth with Strong Financial Performance and a Solid Order Book
With an attractive valuation, positive financial outlook, and commitment to innovation, Wabash National $WNC is positioned for success.
Regis Corporation (NYSE:RGS) – Why I Remain Optimistic On Its Turnaround
Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.
Haw Par Group (SGX:H02) – A Simple Analysis II
I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.
2022 Portfolio Review -A Quick Look Back, Then Start Looking Forward
My annual investment review for 2022. This year has been a rollercoaster for the stock market, here are the key takeaways from my portfolio.
uniQure NV (NASDAQ:QURE) – A Prognosis
We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.
VolitionRx Limited (NYSE: VNRX) – Enters Commercial Stage for Nu.Q Vet Cancer Test
VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.
uniQure N.V. (NASDAQ:QURE) – World’s Most Expensive Medicine
uniQure's AMT-061 is currently the world's most expensive drug. Here's why investing in $QURE may be rewarded with strong returns.
Insider Buy Superstocks by Jesse Stine
Here is my summary and review of "Insider Buy Superstocks". It has some important concepts to achieve great investment returns.